Anchiano Therapeutics Ltd. announced unaudited earnings results for the first quarter ended March 31, 2019. For the quarter, the company reported operating loss was USD 5,434,000 compared to USD 3,401,000 a year ago. Net loss for the first quarter of 2019 was approximately USD 18.4 million, or USD 0.70 per share, compared to approximately USD 3.5 million, or USD 0.37 per share in the first quarter of 2018.